Proactive Investors - Run By Investors For Investors

Canntab Therapeutics hoping to bring their slow release tablet tech to U.S.

CannTab Therapeutics (CSE:PILL) CEO Jeff Renwick and Chief Financial officer Richard Goldstein sat down with Steve Darling from Proactive Investors at the LD Microcap conference in Los Angeles to talk about their company and their slow release tablets. They also chatted about the U.S. market and the potential for growth.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here  
View full PILL profile View Profile

Canntab Therapeutics Ltd Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use